Levetiracetam Pensa (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a crucial role in neurotransmitter release. This binding modulates synaptic transmission, decreasing excessive neuronal firing and stabilizing neuronal networks, thereby preventing the initiation and spread of seizure activity.

The dosage of Levetiracetam Pensa is individualized and determined by the prescribing clinician based on the patient’s age, weight, renal function, seizure type, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for levetiracetam in pregnancy and lactation are limited. The potential benefits and risks should be carefully evaluated by a healthcare professional. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss treatment options with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It generally has fewer drug‑enzyme interactions, a favorable tolerability profile, and can be used as monotherapy or adjunct therapy, making it a versatile option in many seizure types.

Levetiracetam Pensa should be stored at room temperature, below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity.

Levetiracetam Pensa is taken orally, usually with or without food, as directed by the prescriber. The tablets (or other oral form) should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, significant mood changes including depression or suicidal thoughts, and rare blood disorders. Patients should seek immediate medical attention if they experience rash, swelling, breathing difficulties, profound mood changes, or unexplained bruising or bleeding.

Levetiracetam Pensa is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications that may markedly reduce its efficacy.